These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7993997)

  • 1. Reduced production, absorption, and elimination of erythropoietin in uremia compared with healthy volunteers.
    Jensen JD; Madsen JK; Jensen LW; Pedersen EB
    J Am Soc Nephrol; 1994 Aug; 5(2):177-85. PubMed ID: 7993997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of intraperitoneal, intravenous, and subcutaneous recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Ateshkadi A; Johnson CA; Oxton LL; Hammond TG; Bohenek WS; Zimmerman SW
    Am J Kidney Dis; 1993 Jun; 21(6):635-42. PubMed ID: 8503418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Macdougall IC; Roberts DE; Neubert P; Dharmasena AD; Coles GA; Williams JD
    Lancet; 1989 Feb; 1(8635):425-7. PubMed ID: 2563798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and pharmacodynamic studies on recombinant human erythropoietin.
    Salmonson T
    Scand J Urol Nephrol Suppl; 1990; 129():1-66. PubMed ID: 2255869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolism of erythropoietin in liver cirrhosis patients compared with healthy volunteers.
    Jensen JD; Jensen LW; Madsen JK; Poulsen L
    Eur J Haematol; 1995 Feb; 54(2):111-6. PubMed ID: 7698293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of recombinant human erythropoietin in chronic haemodialysis patients.
    Nielsen OJ
    Pharmacol Toxicol; 1990 Feb; 66(2):83-6. PubMed ID: 2315268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction of anemia using self-administered daily subcutaneous erythropoietin in uremic patients on continuous ambulatory peritoneal dialysis.
    Li PK; Leung CB; Lui SF; Leung JC; Shek AC; Lai KN
    Int J Artif Organs; 1993 Jul; 16(7):510-4. PubMed ID: 8370605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pharmacokinetics of recombinant erythropoietin administered by the intravenous, subcutaneous, and intraperitoneal routes in continuous ambulatory peritoneal dialysis (CAPD) patients.
    Boelaert JR; Schurgers ML; Matthys EG; Belpaire FM; Daneels RF; De Cre MJ; Bogaert MG
    Perit Dial Int; 1989; 9(2):95-8. PubMed ID: 2488207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of recombinant human erythropoietin after intravenous and subcutaneous administration to healthy subjects.
    Salmonson T; Danielson BG; Wikström B
    Br J Clin Pharmacol; 1990 Jun; 29(6):709-13. PubMed ID: 2378790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of dose requirement, serum erythropoietin and blood pressure following intravenous and subcutaneous erythropoietin treatment of dialysis patients. IV and SC erythropoietin.
    Jensen JD; Madsen JK; Jensen LW
    Eur J Clin Pharmacol; 1996; 50(3):171-7. PubMed ID: 8737755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of recombinant human erythropoietin in children with chronic renal failure.
    Cakar N; Ekim M; Tümer N; Yalçinkaya F; Akar N; Onaran HO
    Int Urol Nephrol; 1997; 29(3):377-83. PubMed ID: 9285314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics of intraperitoneal erythropoietin administered undiluted or diluted in dialysate.
    Bargman JM; Jones JE; Petro JM
    Perit Dial Int; 1992; 12(4):369-72. PubMed ID: 1420495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of subcutaneous and intraperitoneal administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Lui SF; Chung WW; Leung CB; Chan K; Lai KN
    Clin Nephrol; 1990 Jan; 33(1):47-51. PubMed ID: 2302870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacology and economics of recombinant human erythropoietin in end-stage renal disease: the case for subcutaneous administration.
    Besarab A; Flaharty KK; Erslev AJ; McCrea JB; Vlasses PH; Medina F; Caro J; Morris E
    J Am Soc Nephrol; 1992 Mar; 2(9):1405-16. PubMed ID: 1627763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interpatient variation in response to subcutaneous versus intravenous low dose erythropoietin.
    Barclay PG; Fischer ER; Harris DC
    Clin Nephrol; 1993 Nov; 40(5):277-80. PubMed ID: 8281716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of recombinant human erythropoietin in dialysis patients after single and multiple subcutaneous administrations.
    Kampf D; Eckardt KU; Fischer HC; Schmalisch C; Ehmer B; Schostak M
    Nephron; 1992; 61(4):393-8. PubMed ID: 1501734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of recombinant human erythropoietin applied subcutaneously to children with chronic renal failure.
    Braun A; Ding R; Seidel C; Fies T; Kurtz A; Schärer K
    Pediatr Nephrol; 1993 Feb; 7(1):61-4. PubMed ID: 8439481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacokinetics of recombinant human erythropoietin after subcutaneous injection at different sites.
    Jensen JD; Jensen LW; Madsen JK
    Eur J Clin Pharmacol; 1994; 46(4):333-7. PubMed ID: 7957518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recombinant human erythropoietin in uremic patients in substitute treatment].
    Canaud B; Mion C
    Rev Prat; 1992 Feb; 42(4):432-40. PubMed ID: 1604162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of recombinant human erythropoietin treatment in pre-dialysis patients: results of a multicenter study.
    Albertazzi A; Di Liberato L; Daniele F; Battistel V; Colombi L
    Int J Artif Organs; 1998 Jan; 21(1):12-8. PubMed ID: 9554820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.